Open AccessPhase III Study of Two Different Dosing Schedules of Erythropoietin in Anemic Patients With Cancer
Author(s) -
David P. Steensma,
R Molina,
Jeff A. Sloan,
Daniel A. Nikcevich,
Paul Schaefer,
Kendrith M. Rowland,
Todor Dentchev,
Paul J. Novotny,
Loren K. Tschetter,
Steven R. Alberts,
Thomas F. Hogan,
Amy Law,
Charles L. Loprinzi
Publication year - 2006
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2005.02.7276
Subject(s) - medicine , epoetin alfa , anemia , erythropoietin , dosing , quality of life (healthcare) , hemoglobin , cancer , surgery , nursing
To compare maintenance epoetin alfa administered once every 3 weeks with continued weekly epoetin alfa for patients with cancer-associated anemia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom